Truist Securities expressed a positive outlook on Boston Scientific (NYSE:BSX) shares, raising the price target to $120 from $110, while reaffirming a Buy rating. The stock, currently trading near its ...
If you don’t qualify for the best cash offers this month — and most will not — we’ve included the 5 most accessible sign-up ...
In a report released today, William Stein from Truist Financial maintained a Buy rating on TTM Technologies (TTMI – Research Report). The ...
Truist Securities adjusted its outlook on TTM Technologies (NASDAQ:TTMI), a leading global printed circuit board (PCB) manufacturer, by increasing the price target to $38.00, up from the previous $32.